Articles tagged with Covid 19 Vaccines
A new study suggests that blood cancer patients receiving Bruton Tyrosine Kinase inhibitors should continue their therapy while getting vaccinated against COVID-19. The IMPROVE trial found no improvement in antibody responses when BTKi therapy was paused for three weeks around the time of vaccination.
A new study by researchers at McGill University found that annual COVID-19 vaccine booster doses help avoid breakthrough infections in people with immune-mediated inflammatory diseases. The study tracked 366 patients across Canada and used saliva PCR tests and antibody measurements, offering a more precise picture of infection risks.
The University of Texas at Arlington expert discusses the state's largest outbreak in 30 years, with fewer people getting vaccinated contributing to its spread. The MMR vaccine is 97% effective against measles and has been proven safe despite misconceptions about its safety.
Researchers at Lancaster University discovered a new type of vaccine-specific scepticism, where some people perceive COVID-19 vaccines as 'not a vaccine' compared to MMR. This phenomenon may also apply to the flu vaccine, highlighting the need for clear public health messaging.
Researchers found that mRNA-based COVID-19 vaccines cause persistent epigenetic changes in monocyte-derived macrophages, enabling a sustained immune response. These changes were preserved for six months after vaccination and required multiple doses to maintain long-term immunity.
Researchers developed a universal vaccine that removes sugar molecules from coronavirus spike proteins, creating effective antibodies. The vaccine showed improved protection against various variants and potential applications for cancer treatment.
A major clinical trial has identified ensitrelvir as an effective medication to prevent symptomatic COVID-19 in people exposed within households. The trial showed a 67% reduction in risk of illness among participants taking the antiviral compared to those given a placebo.
A new study published in PLOS Medicine estimates that the COVID-19 pandemic cost Europe 16.8 million disability-free years of life between 2020 and 2022. The study found that more than half of these lost years would have been lived without disability, highlighting the pandemic's long-term impact on older populations.
A Canadian-developed, needle-free COVID-19 vaccine has begun phase-2 human trials, testing its efficacy and safety in a broad study group. The trial aims to evaluate the vaccine's ability to induce immune responses and prevent recurrent infections, with researchers hoping to include 350 participants from across Canada.
Researchers developed a new vaccine platform that provides robust, long-lasting protection against multiple flu strains and COVID-19. The vaccine boasts 100% survival rates in vaccinated mice following challenge with either virus.
Researchers report an increase in adult VZV-related CNS infections, particularly since 2019, with a notable rise in aseptic meningitis cases. The study suggests that universal varicella vaccination may be contributing to the decline in natural immunity, leading to reactivation and CNS complications.
A new study suggests that mRNA COVID-19 vaccination may protect against post-COVID condition symptoms in children. The findings support the benefits of vaccination beyond acute protection, encouraging increased pediatric uptake.
A recent study from the University of Kansas found that people tend to prefer AI chatbots when discussing sensitive or embarrassing topics like health information, due to their anonymity and nonjudgmental nature. However, when individuals are angry, they still prefer human interaction.
A cohort study found no increase in sudden cardiac arrest/sudden cardiac death among young competitive athletes in the US, contradicting reports that linked COVID-19 infection and vaccination to the risk. The study suggests that many athlete cases shown in social media videos occurred before the pandemic, not due to COVID-19.
A study published in Nature Cardiovascular Research identified distinct immune signatures in myocarditis caused by SARS-CoV-2 infection and mRNA vaccines compared to non-COVID-19 myocarditis. The findings suggest a stronger immune response in post-COVID-19 myocarditis, while the inflammation appeared milder in post-vaccination cases.
New UCLA-led research finds that Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults. The study suggests that Paxlovid's potential effect on COVID-19 hospitalization in vaccinated older adults is four times weaker than originally reported.
A team of researchers has identified a new chronic blood clotting disorder, VITT-like monoclonal gammopathy of thrombotic significance (MGTS), characterized by antibodies similar to those causing vaccine-induced immune thrombocytopenia and thrombosis (VITT). The disorder can lead to severe symptoms despite treatment with full-dose bloo...
Immunocompromised individuals require regular vaccine boosters to protect against severe infections and new variants, research shows. Boosters may need to be administered four or more times to offer adequate protection.
A US clinical trial will assess the safety and efficacy of a nasal COVID-19 vaccine developed using technology from Washington University in St. Louis. The trial, sponsored by the National Institute of Allergy and Infectious Diseases, aims to evaluate the vaccine's ability to induce strong immunity in the nose and upper respiratory tract.
Scientists at Tel Aviv University successfully transport mRNA-based drugs to the immune system of small and large intestines without passing through the liver. The breakthrough could enable treatments for inflammatory diseases such as Crohn's and colitis.
Researchers uncovered eight rare diseases that carry significantly increased risks for COVID-19-related mortality in fully vaccinated individuals. These conditions, including infertility disorders and kidney diseases, pose a nearly fivefold greater risk of death from COVID-19 than the general population.
A new survey finds that nearly three-quarters of US adults support requiring children to be vaccinated against preventable diseases, while over half support prohibiting unvaccinated children from attending school. However, support for this prohibition has dropped significantly since the Covid-19 pandemic, and there is growing support f...
A study of 1,700 people found that those who consumed more conservative news were less likely to be vaccinated, but a diverse media diet made them more likely to get vaccinated. People who got their news from an ideologically diverse array of sources were more critical thinkers and less likely to be misled by misinformation.
Researchers developed a nanoparticle-based vaccine that generates antibodies targeting conserved regions of sarbecovirus receptor-binding proteins, offering broader protection against multiple strains. The vaccine demonstrated strong antibody responses and protection in animal studies against diverse SARS-CoV-2 and other sarbecoviruses.
Researchers created a framework to determine the best vaccination strategy for communities with individuals of different risk levels. The framework prioritizes vaccination efforts for high-risk groups, such as the elderly and immunocompromised, or high-contact groups, like essential workers, over baseline populations.
A recent study by Emory University researchers found that mRNA vaccines developed to fight COVID-19 are less effective in patients with autoimmune diseases like lupus. The findings highlight the importance of developing tailored vaccination strategies for this vulnerable population.
Researchers at the University of São Paulo's Medical School have developed a COVID-19 vaccine using virus-like particles (VLPs), which proved highly protective, safe, and versatile in animal trials. The vaccine can be easily updated to combat variants of concern without requiring an adjuvant.
Researchers found that up to 34% of the British public considered acts like nepotism or bribery acceptable during the vaccine rollout. The study also discovered an association between public tolerance of petty corruption and vaccine rollout speed, with slower rollouts in areas where tolerance was higher. Lead author Dr Franziska Sohns ...
A recent study highlights the need for targeted interventions to improve COVID-19 vaccine confidence among Black women in the US. Addressing historical traumas and providing clear safety information are crucial to building trust with this demographic.
Peter Hotez proposes a focus on local data, improved benefit-risk communications, and state-level action to counter US antivaccine sentiment. Childhood vaccinations are becoming increasingly politicized, with multiple preventable illnesses emerging, including whooping cough and measles.
Researchers found that older adults with weakened immunity developed fewer antibodies against RSV following vaccination compared to healthy individuals. The study suggests that adjuvant-enhanced vaccines could improve immune responses in immunocompromised people, warranting further investigation.
According to a new survey, over half of U.S. adults believe the RSV vaccine is effective in protecting infants from the virus, up from 42% last year. The rise in perceived effectiveness comes as several politicians have cast doubt on the vaccine's safety and efficacy.
Researchers provide comprehensive review of RSV's virology, clinical impact, and prevention strategies, emphasizing the need for effective vaccines to mitigate this critical health need. The review highlights RSV's severe impact on infants, children, and older adults, as well as its potential effects on multiple organs and systems.
Research from Radboud University Medical Center shows that lockdowns during the COVID-19 pandemic strengthened the immune system's response to microorganisms. The study found that after lockdowns, inflammation levels in the body were low but the immune system reacted more intensely to viruses and bacteria.
A recent study in the Netherlands has found that COVID-19 vaccination during pregnancy is not associated with adverse health outcomes in infants. The researchers analyzed data from over 3,600 participants and found no significant associations between maternal COVID-19 vaccination and neonatal health issues, including breathing difficul...
The Pfizer-BioNTech XBB vaccine provided protection against severe COVID-19 cases and hospitalizations among children aged 5-17 during the 2023-2024 season. The vaccine showed an estimated vaccine effectiveness of 63-73% in preventing severe illness.
A study published in PLOS Global Public Health found that individuals with high credulity are more susceptible to fake news and vaccine hesitancy. Mistrust was also linked to conspiracy thinking and difficulty distinguishing between real and fake news, particularly in those exposed to childhood adversity.
Researchers found that brief scientific literacy interventions can undermine conspiracy beliefs, particularly those built on faulty reasoning. These interventions were most effective against novel conspiracies and among high-conspiracy groups.
Researchers at Helmholtz Munich identified a mechanism explaining Long COVID's neurological symptoms: SARS-CoV-2 spike protein remains in the brain for up to four years after infection. mRNA COVID-19 vaccines significantly reduce spike protein accumulation, but persistent presence poses a toxic risk.
The study found that irritability was the most common systemic reaction in children under 2 years, followed by fever and fatigue or sleepiness. Maternal vaccination is thought to be a factor in the higher prevalence of reactions after the first dose.
A recent study surveyed over 1,000 English-dominant, bilingual, and Spanish-dominant Latino users of Facebook and Instagram in the US. Latinos who use Spanish-language social media for news were found to be more susceptible to false political narratives, with a 11 percentage point increase in belief in these claims.
A Korean University College of Medicine study investigated COVID-19 vaccine safety in patients with atrial fibrillation/flutter. The research found no significant increase in the risk of thromboembolic events following COVID-19 vaccination, but patients without anticoagulant therapy were at higher risk. The study highlights the importa...
A unique COVID-19 and flu vaccine clinic at the UC Davis MIND Institute has shown remarkable success in increasing vaccination rates among individuals with neurodevelopmental disabilities. The clinic's innovative approach, which incorporates community partners and tailored care plans, has resulted in a 99.3% success rate over two years.
Researchers at Kumamoto University have developed a cutting-edge diagnostic tool, Intelli-OVI, to rapidly identify emerging SARS-CoV-2 variants. This system combines advanced DNA detection technology with computational algorithms to offer a quicker and more cost-effective method of monitoring viral mutations.
A randomized clinical trial found that simultaneous administration of mRNA COVID-19 and inactivated influenza vaccines had comparable reactogenicity to sequential administration. This suggests a safe option for co-administration of these vaccines.
A retrospective cohort study found associations between COVID-19 and the long-term risk of various autoimmune and autoinflammatory connective tissue disorders. Long-term monitoring and care are crucial to mitigate these risks, taking into account demographic factors, disease severity, and vaccination status.
A Rutgers University study found that COVID-19 vaccination rates were exceptionally high among LGBTQ+ adults in New Jersey and New York, but HPV vaccination had the lowest uptake rates. The study highlights age as a key predictor of vaccination uptake for most vaccines studied.
A study found that around one-third of respondents expressed mistrust in COVID-19 vaccines, with individuals who lost loved ones being nearly four times more likely to trust the science. Higher trust levels were associated with male respondents, university degrees, and above-median incomes.
A new study aims to improve vaccination rates and create new strategies to break down barriers to vaccination in populations with limited access to healthcare. The research team will develop a multilevel intervention strategy to increase vaccine uptake among adults, adolescents, families, and communities.
A new study at an allergy clinic in a diverse community found that self-identified non-White patients were less likely to show vaccine hesitancy than the White patient group. Ethnicities included in the study showed Black, Hispanic and Asian ethnicities with lower rates of refusal compared to Whites.
Researchers found that repeated mRNA vaccines enhance mucosal antibodies in nasal secretions, blocking viral entry and providing sustained protection. The immune responses generated by mRNA vaccines may persist longer than previously thought, offering hope for sustained protection against emerging COVID-19 variants.
Researchers at Nagoya University developed an innovative synthesis technology to produce high-purity, fully chemically synthesized mRNA. This breakthrough cuts down the production time and can be used to address concerns about purity and speed in mRNA vaccine development.
A groundbreaking initiative in Prince George's County, Maryland, has successfully combated COVID-19 vaccine disparities by leveraging community health workers to promote health literacy and vaccine equity. The Health Literacy Enhancement and Advancement Program (Health LEAP) reached over 14,800 residents, particularly Black and Hispani...
A new study found that COVID-19 infection increased the risk of heart attack and stroke for up to three years after infection. The risk was higher among people with A, B or AB blood types compared to type O, according to researchers analyzing data in the UK Biobank.
The authors emphasize the importance of increasing vaccination rates to combat decreasing rates globally. They also highlight emerging challenges such as a highly virulent strain of influenza and measles outbreaks, particularly in areas with low vaccination rates.
Researchers at La Jolla Institute for Immunology have developed six lines of humanized mice to study human cases of COVID-19, shedding light on SARS-CoV-2's movement through the body and varying symptoms. The models help understand how different genetic backgrounds influence disease progression.
A nationwide Swedish study found that full vaccination significantly reduced the risk of severe cardiovascular outcomes linked to COVID-19, such as heart attack and stroke. However, temporary increases in cardiovascular risk were observed after individual doses, particularly among elderly and males.
A multinational study found that people with unmedicated mental illness are less likely to be vaccinated against COVID-19, with a 9% lower vaccination rate compared to the general population. Individuals with substance use disorder were also 16% less likely to receive the vaccine.
A new poll from Michigan Medicine shows that nearly half of people age 50 and older plan to get the updated COVID-19 vaccine. However, some older adults with high risk of severe illness appear unlikely to seek the vaccine, highlighting the need for increased encouragement from clinicians and other sources.
Researchers at Boston University discovered a new method to harness self-amplifying RNA to create more effective vaccines. The modified saRNA vaccine protected mice from severe COVID-19 disease with a lower dose than current mRNA vaccines. Longer duration of protein expression and reduced inflammation were also observed.